Your Messages Inbox
Your Article Summary
See Latest ArticlesAvigen Reports Third Quarter 2008 Financial Results
Avigen, 01/09/09
Avigen, Inc., a biopharmaceutical company innovating therapeutics for neurological care, reported financial results. Avigen had approximately $56 million in financial assets, including cash, cash equivalents, and available-for-sale securities and restricted investments, compared with approximately $78 million at December 31, 2007.
| Previous Article | Next Article |
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday, July
BioMarin, 07/02/09
Alcon Announces Second Quarter 2009 Financial Release and Conference Call Dates
Alcon, 07/02/09
Cephalon Quarterly Conference Call Invitation
Cephalon, 07/01/09
Article Search
Sponsor